SIC
BNGO icon

SJS Investment Consulting’s Bionano Genomics BNGO Stock Holding History

SJS Investment Consulting’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1K Hold
1
– – ﹤0.01% 550
2021
Q4 		$1K Buy
+1
New +$2.67K ﹤0.01% 487

Other funds holding BNGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

SJS Investment Consulting's BNGO Position: Q1 2022 in Review

SJS Investment Consulting held its Bionano Genomics (BNGO) position steady in Q1 2022 at 1 share worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

SJS Investment Consulting first reported a position in BNGO in Q4 2021 and has held it in 2 quarters since. 148 funds tracked by Wall St. Rank hold BNGO as of Q1 2022.

  • SJS Investment Consulting held 1 share of Bionano Genomics worth $1K as of Q1 2022.
  • SJS Investment Consulting left its Bionano Genomics share count unchanged in Q1 2022.
  • Bionano Genomics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q1 2022, its #550 holding.
  • SJS Investment Consulting first reported a position in Bionano Genomics in Q4 2021 and has held it in 2 quarters since.
  • 148 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2022.

Based on SJS Investment Consulting's 13F filing for Q1 2022, filed 5 May 2022.